Norman Sharpless - 04 Aug 2022 Form 4 Insider Report for G1 Therapeutics, Inc.

Role
Director
Signature
/s/ James Stillman Hanson, attorney-in-fact
Issuer symbol
N/A
Transactions as of
04 Aug 2022
Net transactions value
$0
Form type
4
Filing time
05 Aug 2022, 16:15:53 UTC
Previous filing
02 Aug 2022
Next filing
16 Jun 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTHX Stock Options (Right to Buy) Award $0 +60,000 $0.000000 60,000 04 Aug 2022 Common Stock 60,000 $10.49 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying this option vest in 36 equal monthly installments beginning August 31, 2022, subject to the Reporting Person's continued service through each applicable vesting date.